Author:
ERDMANN Erland,SPANHEIMER Robert,CHARBONNEL Bernard,
Subject
Endocrinology, Diabetes and Metabolism
Reference42 articles.
1. Polypharmacy as a risk factor in the treatment of T2DM;Austin;Diabetes Spectr,2006
2. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD);Rydén;Eur Heart J,2007
3. Rosiglitazone and myocardial infarction: cause for concern or misleading meta-analysis?;Bilous;Diabet Med,2007
4. Misleading meta-analysis: a need to look beyond the headlines;Chaturvedi;Diabet Med,2007
5. Rosiglitazone and implications for pharmacovigilance;Kazi;BMJ,2007
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献